Cargando…
In silico screening of herbal and nanoparticle lead compounds for effectivity against H5N1, H1N1 neuraminidase and telomerase
This article has been withdrawn from the public domain because of significant plagiarism. In the light of this situation, BioMed Central regrets that this article is no longer available. The authors apologise to all affected parties for the inconvenience.
Autores principales: | Ganguli, Sayak, Mazumder, Manjita, Basu, Protip, Roy, Paushali, Mitra, Sayani, Datta, Abhijit |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2872820/ https://www.ncbi.nlm.nih.gov/pubmed/20122184 http://dx.doi.org/10.1186/1471-2105-11-S1-S13 |
Ejemplares similares
-
Retraction: In silico screening of herbal and nanoparticle lead compounds for effectivity against H5N1, H1N1 neuraminidase and telomerase
por: Ganguli, Sayak, et al.
Publicado: (2010) -
Lysine richness in human snurps possible sites for electrophilic attacks
por: Dey, Sanjay Kumar, et al.
Publicado: (2010) -
Targeting pseudoknots in H5N1 hemagglutinin using designed aptamers
por: Dhar,, et al.
Publicado: (2009) -
In silico modification of oseltamivir as neuraminidase inhibitor of influenza A virus subtype H1N1
por: Tambunan, Usman Sumo Friend, et al.
Publicado: (2015) -
In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain
por: Hussain Basha, Syed, et al.
Publicado: (2012)